2
Total investments
2
Early stage
0
Mid stage
0
Late stage
7y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Dec 2024
At Okeiro, we develop precision medicine solutions that transform the monitoring of transplant patients and those with chronic conditions.
Our predictive algorithms, scientifically validated digital biomarkers, convert complex medical data into information directly usable by healthcare teams. This technology allows us to:
- Detect early signals of complications or graft rejection
- Personalize each treatment for truly proactive care
- Intervene before critical symptoms appear
Our goal is clear: to tangibly improve patients lives by equipping healthcare professionals with innovative tools that make a daily difference.
In close collaboration with healthcare professionals and pharmaceutical companies, we accelerate the clinical validation of therapeutic innovations to make new treatments more quickly accessible to the patients who need them!
We dont perform miracles, just create the tools that enable them.
VC Investor
Jan 2019
RRW is a cross-border hands-on VC firm that supports EU tech start-ups in their growth in the US.
A unique combination of a renowned French-based investor -Groupe Artémis- and a successful US-based entrepreneurial team and network.
Red River West promotes the international take-off of outstanding Fr/EUTech companies by providing significant financial firepower and game changing hands-on support in EU & the US.
Experience · 4 entries
All (4)
Investments (2)
Board (1)
2024
Board Member
Dec 2024
At Okeiro, we develop precision medicine solutions that transform the monitoring of transplant patients and those with chronic conditions.
Our predictive algorithms, scientifically validated digital biomarkers, convert complex medical data into information directly usable by healthcare teams. This technology allows us to:
- Detect early signals of complications or graft rejection
- Personalize each treatment for truly proactive care
- Intervene before critical symptoms appear
Our goal is clear: to tangibly improve patients lives by equipping healthcare professionals with innovative tools that make a daily difference.
In close collaboration with healthcare professionals and pharmaceutical companies, we accelerate the clinical validation of therapeutic innovations to make new treatments more quickly accessible to the patients who need them!
We dont perform miracles, just create the tools that enable them.
2019
Private Equity Analyst
Jan 2019
Artemis is the holding company of the Pinault family.
Founded in 1992, Artemis carries out long term investments in companies with strong growth potential.
Over the past 30 years, Artémis has built a substantial and balanced portfolio of assets with strong international brands, the majority of which operate across the broad spectrum of the luxury goods and services sector.
Its consolidated assets are currently valued at some €40 billion.
Artémis is led by a tight-knit team whose members manage all investment decisions and provide portfolio oversight.
Our Portfolio
Artémis is the controlling shareholder of Kering, one of the world leaders in Luxury.
Artémis also owns Christie’s, the worldwide leading auction house, several prestigious vineyards, including Château Latour, rated a “Premier Cru Classé” since 1855, the French luxury cruise ships company Ponant, the newsmagazine Le Point and the Stade Rennais Football Club.
VC Investor
Jan 2019
RRW is a cross-border hands-on VC firm that supports EU tech start-ups in their growth in the US.
A unique combination of a renowned French-based investor -Groupe Artémis- and a successful US-based entrepreneurial team and network.
Red River West promotes the international take-off of outstanding Fr/EUTech companies by providing significant financial firepower and game changing hands-on support in EU & the US.
2018
VC Analyst
Feb 2018
We believe the next Tech Leaders will be European
At Korelya Capital, we believe digital investment opportunities can trigger growth and social progress in Europe. The digital revolution has already started to disrupt the way we live, work, have access to knowledge, culture and information, the way we produce, the way we consume, the way we interact with each other’s. Tomorrow, it will free us of repetitive tasks, change our relation to the city, facilitate travel and limit our exposure to risks.
We also believe that unprecedented success stories in the digital economy will emerge from Europe within the next ten years. The European tech ecosystem is reaching maturity at every levels (mindset, access to capital, tech know how, talent, etc.). Artificial Intelligence, IoT, Big Data, are the ingredients of the next digital revolution, the one that will follow the “platformization” of our economies and societies.
